Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
Submitted by
admin
on March 6, 2017 - 9:47am
Source:
Endpoints
News Tags:
TG Therapeutics
ublituximab
TG-1101
FDA
CLL
Headline:
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
Do Not Allow Advertisers to Use My Personal information